tiprankstipranks
Trending News
More News >
Traws Pharma (TRAW)
NASDAQ:TRAW
US Market
Advertisement

Traws Pharma (TRAW) Income Statement

Compare
1,856 Followers

Traws Pharma Income Statement

Last quarter (Q2 2025), Traws Pharma's total revenue was $2.73M, an increase of 4694.74% from the same quarter last year. In Q2, Traws Pharma's net income was $-915.00K. See Traws Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 226.00K$ 226.00K$ 226.00K$ 226.00K$ 231.00K
Gross Profit
$ 214.00K$ 210.00K$ 212.00K$ 212.00K$ 0.00
Operating Expenses
$ 49.56M$ 20.51M$ 19.84M$ 16.71M$ 25.21M
Depreciation and Amortization
$ 12.00K$ 16.00K$ 14.00K$ 14.00K$ 13.00K
EBITDA
$ -166.51M$ -18.93M$ -18.95M$ -16.15M$ -25.14M
Operating Income
$ -49.35M$ -20.30M$ -19.63M$ -16.50M$ -24.99M
Other Income/Expenses
$ -117.17M$ 1.35M$ 663.00K$ 333.00K$ -160.00K
Pretax Income
$ -166.52M$ -18.95M$ -18.96M$ -16.16M$ -25.15M
Net Income
$ -54.67M$ -18.95M$ -18.96M$ -16.16M$ -25.16M
Per Share Metrics
Basic EPS
$ -35.21$ -22.57$ -22.68$ -24.01$ -54.21
Diluted EPS
$ -35.21$ -22.57$ -22.68$ -24.01$ -54.21
Weighted Average Shares Outstanding
1.55M 839.55K 836.33K 673.29K 464.10K
Weighted Average Shares Outstanding (Diluted)
1.55M 839.55K 836.33K 673.29K 464.10K
Currency in USD

Traws Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis